FDBL - Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Signs First Amendment to its Agreement with Canada's Abbott; Partners with Ellerca Health Inc. For Joint Diabetes Screening and Management Support and Announces Systems Deployment to Select Shoppers Drug
- Avricore, through its subsidiary HealthTab(TM), will now distribute Abbott’s ID Now(TM) molecular testing device following the first amendment to the supplier distribution agreement between the two companies
- This amendment will allow for an improvement in onsite testing and reporting capabilities for SARS-CoV-2, along with RSV, Influenza A & B and Strep
- Avricore also announced its partnership with Ellerca Health Inc., in a move to utilize Ellerca’s technologies and service while focusing on diabetes screening and management
- Avricore also marked a huge milestone with the HealthTab(TM) system's deployment in specific Shoppers Drug Mart(R) locations
On July 26, 2021, Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) announced that it had signed its first amendment to its supplier distribution agreement with Abbott.
The initial agreement, which was signed on May 31, 2021, was meant to allow HealthTab(TM) Inc., a subsidiary owned by Avricore, to distribute Canada Abbott’s Afinion(TM) 2 plus associated tests for heart disease and diabetes screening in...
NOTE TO INVESTORS: The latest news and updates relating to AVCRF are available in the company’s newsroom at http://ibn.fm/AVCRF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.
With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.
Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com
InvestorWire is part of the InvestorBrandNetwork.